eBee VISION 2.1.0 is capable of continuing missions in GNSS-denied environments and allows manual deactivation of GNSS to ...

ProPhase Labs (PRPH) is focused on immediate cash generation through two key initiatives: strategic alternatives including a potential sale of ...

Tuesday named Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company’s expansion into ...

ProPhase Labs (PRPH) appointed Stu Hollenshead as COO. Following the sale of Pharmaloz Manufacturing, COO Jed Latkin has resigned and ...

GARDEN CITY, NY - 专注于生物科技、基因组学和消费品的ProPhase Labs, Inc.（纳斯达克代码：PRPH）今日宣布任命Stu Hollenshead为首席运营官。根据 InvestingPro 数据显示，该公司目前市值为$7.76百万，正面临重大运营挑战，此次任命是公司加强消费者健康和保健产品战略布局的一部分。

Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational ...

ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced the appointment of Stu Hollenshead as Chief ...

Equities researchers at Diamond Equity lowered their FY2024 earnings per share estimates for shares of ProPhase Labs in a research report issued on Thursday, February 13th. Diamond Equity analyst H.

Equities research analysts at StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the stock.